Company / Operating Cash Flow per Share
BioAge Labs, Inc. Operating Cash Flow per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.28
FY2025
5-year range
-$22.34 / -$2.28
FY2023-FY2025
Trend
+52.6%
vs FY2024
Sector context
#153 of 212
Health Care
What the data says
At $-2.28, BioAge Labs, Inc.'s operating cash flow per share ranks #153 of 212 in the Health Care sector. Improved from $-22.34 to $-2.28 over the past 2 years.
Based on SEC 10-K filings.
-2.28 in FY2025.
Improved from $-22.34 to $-2.28 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#153 of 212 in Health CareTop 72% of 212This company -$2.28 Sector average -$14.72
▼
+84.5% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 52.6% year-over-year.
- Ranks #153 out of 212 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.28 | +52.6% |
| FY2024 | -$4.80 | +78.5% |
| FY2023 | -$22.34 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026